The type of<unk>  a person has informs the choice of treatment. Mild cases are often not treated at all, or are simply covered up with normal cosmetics. Therapy for the treatment of<unk>  is not curative, and is best measured in terms of reduction in the amount of facial redness and inflammatory lesions, a decrease in the number, duration, and intensity of flares, and concomitant symptoms of itching, burning, and tenderness. The two primary modalities of<unk>  treatment are topical and oral antibiotic agents. Laser therapy has also been classified as a form of treatment. While medications often produce a temporary remission of redness within a few weeks, the redness typically returns shortly after treatment is suspended. Long-term treatment, usually 1–2 years, may result in permanent control of the condition for some patients. Lifelong treatment is often necessary, although some cases resolve after a while and go into a permanent remission. Other cases, if left untreated, worsen over time. Behavior Avoiding triggers that worsen the condition can help reduce the onset of<unk> , but alone will not normally lead to remission except in mild cases. Keeping a journal is sometimes recommended to help identify and reduce food and beverage triggers. Because sunlight is a common trigger, avoiding excessive exposure to the sun is widely recommended. Some people with<unk>  benefit from daily use of a sunscreen; others opt for wearing hats with broad brims. Like sunlight, emotional stress can also trigger<unk> . People who develop infections of the eyelids must practice frequent eyelid hygiene. Managing pretrigger events such as prolonged exposure to cool environments can directly influence warm-room flushing. Medications Medications with good evidence include topical ivermectin and azelaic acid creams and brimonidine, and doxycycline and isotretinoin by mouth. Lesser evidence supports topical metronidazole cream and tetracycline by mouth. Metronidazole is thought to act through anti-inflammatory mechanisms, while azelaic acid is thought to decrease cathelicidin production. Oral antibiotics of the tetracycline class such as doxycycline, minocycline, and oxytetracycline are also commonly used and thought to reduce papulopustular lesions through anti-inflammatory actions rather than through their antibacterial capabilities. Using alpha-hydroxy acid peels may help relieve redness caused by irritation, and reduce papules and pustules associated with<unk> . Oral antibiotics may help to relieve symptoms of ocular<unk> . If papules and pustules persist, then sometimes isotretinoin can be prescribed. The flushing and blushing that typically accompany<unk>  are typically treated with the topical application of alpha agonists such as brimonidine and less commonly oxymetazoline or xylometazoline. A review found that ivermectin was more effective than alternatives for treatment of papulopustular acne<unk> . An ivermectin cream has been approved by the FDA, as well as in Europe, for the treatment of inflammatory lesions of<unk> . The treatment is based upon the hypothesis that parasitic mites of the genus Demodex play a role in<unk> . In a clinical study, ivermectin reduced lesions by 83% over 4 months, as compared to 74% under a metronidazole standard therapy. Laser Evidence for the use of laser and intense pulsed-light therapy in<unk>  is poor.
Rosacea
Dermatomyositis
Ocular rosacea
Acne
Steroid rosacea
Seborrhoeic dermatitis
Pomade acne
Lupus